Shares of solid tumor concern Zymeworks Inc. have barely budged since the company obtained its first approval. Click here to read why ZYME stock is a Hold.

Major Crypto Exchanges Launch New Products, Obtain Foreign Licenses - According to a recent company blog post, a major ...

New range, power, performance and suspension tech reinforce the position of one of the world's greatest sporting EVs ...

Despite rising interest rates, RioCan REIT maintains high occupancy and stable earnings. Find out why RIOCF stock could be a ...

Drosera acts as Ethereum’s immune system by arming protocols with the ability to detect and neutralize threats before they ...

The acting leader is a co-author of the conservative playbook in which a former Fannie Mae and HUD director calls for abolishing the regulator.

From sheepskin seat covers to disastrous V8 engines, there have been some bad car trends over the years. Here are the ones we ...

Researchers have developed a new material that could help to remove unwanted pollutants — including leftover medicines and ...

Ataccama, the data trust company, today announced the appointments of Scott Lewis as Chief Customer Officer (CCO) and Matthew Lane as Chief Revenue Officer (CRO). The leadership team expansion ...

Investment will support new product development, go-to-market acceleration and geographic expansion, strengthening Validus’ position as a leading software and tech-enabled platform for private markets ...

Calculators are essential classroom tools, enabling students to perform complex math operations accurately and efficiently.

The following highlights showcase the most pivotal, innovative research published across multiple therapeutic areas in ...